Xiaolin Wan

3.0k total citations · 2 hit papers
28 papers, 2.4k citations indexed

About

Xiaolin Wan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaolin Wan has authored 28 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Xiaolin Wan's work include Sarcoma Diagnosis and Treatment (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cell Adhesion Molecules Research (4 papers). Xiaolin Wan is often cited by papers focused on Sarcoma Diagnosis and Treatment (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers) and Cell Adhesion Molecules Research (4 papers). Xiaolin Wan collaborates with scholars based in United States, China and Canada. Xiaolin Wan's co-authors include Lee J. Helman, Chand Khanna, Arnulfo Mendoza, Patrick J. Grohar, Choh Yeung, Stephen M. Hewitt, Osarenoma Olomu, Richard Görlick, Ryan D. Cassaday and Na Shen and has published in prestigious journals such as Advanced Materials, Nature Medicine and Advanced Functional Materials.

In The Last Decade

Xiaolin Wan

26 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism

2006 630 citations Xiaolin Wan, Patrick J. Grohar et al. Oncogene profile →
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

2004 572 citations Chand Khanna, Xiaolin Wan et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaolin Wan United States	17	1.5k	742	549	420	300	28	2.4k
Arnulfo Mendoza United States	26	1.5k 1.0×	789 1.1×	965 1.8×	636 1.5×	312 1.0×	51	2.8k
Barbara Sennino United States	28	2.0k 1.4×	698 0.9×	1.1k 2.0×	817 1.9×	121 0.4×	47	3.8k
Makoto Saegusa Japan	38	1.8k 1.2×	565 0.8×	1.3k 2.4×	680 1.6×	199 0.7×	163	3.8k
Emiliano Cocco United States	32	1.1k 0.7×	833 1.1×	1.6k 2.8×	532 1.3×	150 0.5×	83	3.2k
Inge H. Briaire‐de Bruijn Netherlands	29	1.0k 0.7×	1.1k 1.5×	714 1.3×	467 1.1×	226 0.8×	65	2.7k
Raushan T. Kurmasheva United States	27	1.3k 0.9×	546 0.7×	814 1.5×	366 0.9×	315 1.1×	120	2.3k
Benoît Lhermitte France	18	821 0.6×	702 0.9×	710 1.3×	647 1.5×	187 0.6×	77	2.5k
Aasmund Berner Norway	33	1.2k 0.8×	873 1.2×	960 1.7×	582 1.4×	73 0.2×	99	3.3k
Ralph M. Wirtz Germany	31	2.1k 1.5×	520 0.7×	1.3k 2.4×	780 1.9×	103 0.3×	151	3.8k
Masato Kochi Japan	31	907 0.6×	660 0.9×	468 0.9×	413 1.0×	672 2.2×	86	4.5k

Countries citing papers authored by Xiaolin Wan

Since Specialization

Citations

This map shows the geographic impact of Xiaolin Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Wan more than expected).

Fields of papers citing papers by Xiaolin Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Wan. The network helps show where Xiaolin Wan may publish in the future.

Co-authorship network of co-authors of Xiaolin Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Wan. A scholar is included among the top collaborators of Xiaolin Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Wan. Xiaolin Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wan, Xiaolin, et al.. (2025). Higher-order band topology in a twisted bilayer kagome lattice. Physical review. B.. 111(8).

Zheng, Kai, Xiaolin Wan, Qiang Xiao, et al.. (2024). Chinese traditional medicine DZGP beneficially affects gut microbiome, serum metabolites and recovery from rheumatoid arthritis through mediating NF-κB signaling pathway. Heliyon. 10(13). e33706–e33706. 3 indexed citations

Xie, Hongyao, Xiaolin Wan, Yasong Wu, et al.. (2024). Topological Electronic Transition Contributing to Improved Thermoelectric Performance in p‐Type Mg₃Sb₂₋_xBi_x Solid Solutions. Advanced Materials. 36(26). e2400845–e2400845. 21 indexed citations

He, Ling, et al.. (2023). SIRT4 in ageing. Biogerontology. 24(3). 347–362. 13 indexed citations

Yohe, Marielle E., Kai Pollard, Angelina V. Vaseva, et al.. (2022). Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma. Oncogene. 41(21). 2973–2983. 28 indexed citations

Chen, Jieqiong, et al.. (2022). Cognitive Impairment in Phenotypic Leber Hereditary Optic Neuropathy Caused by Mutation in Nuclear Gene NDUFAF5. Journal of Neuro-Ophthalmology. 44(1). e20–e22.

Luo, Qinghua, Xiaolin Wan, Bing‐Xing Pan, et al.. (2019). NEMO-binding domain peptides alleviate perihematomal inflammation injury after experimental intracerebral hemorrhage. Neuroscience. 409. 43–57. 7 indexed citations

Heske, Christine M., Choh Yeung, Arnulfo Mendoza, et al.. (2016). The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma. Translational Oncology. 9(6). 540–547. 10 indexed citations

Wan, Xiaolin, Choh Yeung, Christine M. Heske, Arnulfo Mendoza, & Lee J. Helman. (2015). IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma. Neoplasia. 17(4). 358–366. 40 indexed citations

10.

Yeung, Choh, Vu N. Ngo, Patrick J. Grohar, et al.. (2013). Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth. Oncogene. 32(47). 5429–5438. 36 indexed citations

11.

Kim, Su Young, Xiaolin Wan, & Lee J. Helman. (2009). Targeting IGF-1R in the treatment of sarcomas: past, present and future. Bulletin du Cancer. 96(7). E52–E60. 16 indexed citations

12.

Wan, Xiaolin, So Young Kim, Lillian M. Guenther, et al.. (2009). Beta4 integrin promotes osteosarcoma metastasis and interacts with ezrin. Oncogene. 28(38). 3401–3411. 62 indexed citations

13.

Cao, Liang, Yunkai Yu, Duane Currier, et al.. (2008). Addiction to Elevated Insulin-like Growth Factor I Receptor and Initial Modulation of the AKT Pathway Define the Responsiveness of Rhabdomyosarcoma to the Targeting Antibody. Cancer Research. 68(19). 8039–8048. 122 indexed citations

14.

Petricoin, Emanuel F., Virginia Espina, Robyn P. Araujo, et al.. (2007). Phosphoprotein Pathway Mapping: Akt/Mammalian Target of Rapamycin Activation Is Negatively Associated with Childhood Rhabdomyosarcoma Survival. Cancer Research. 67(7). 3431–3440. 196 indexed citations

15.

Yeung, Choh, et al.. (2007). Evaluation of combined insulin-like growth factor type 1 (IGF1R) and mTOR pathway blockade in sarcoma xenograft models. Cancer Research. 67. 4760–4760. 1 indexed citations

16.

Wan, Xiaolin, Na Shen, Arnulfo Mendoza, Chand Khanna, & Lee J. Helman. (2006). CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling. Neoplasia. 8(5). 394–401. 122 indexed citations

17.

Wan, Xiaolin, et al.. (2006). Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene. 26(13). 1932–1940. 630 indexed citations breakdown →

18.

Khanna, Chand, Xiaolin Wan, Ryan D. Cassaday, et al.. (2004). The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nature Medicine. 10(2). 182–186. 572 indexed citations breakdown →

19.

Wan, Xiaolin & Lee J. Helman. (2003). Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells. Oncogene. 22(50). 8205–8211. 94 indexed citations

20.

Wan, Xiaolin, et al.. (2001). Acidic fibroblast growth factor overexpression partially protects 3T3 fibroblasts from apoptosis induced by synthetic retinoid CD437. Journal of Molecular Medicine. 79(2-3). 143–148. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact